Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (8,546,183)	$ (6,062,360)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and deferred finance costs	1,059,525	1,591,261
Amortization of intangible assets	38,524	245,104
Warrants issued in connection with private placement	2,093,552
Common shares issued in lieu of restricted stock units	226,432
Stock compensation expense	299,890	2,147,591
Depreciation on development equipment	7,609	27,987
Change in fair value of derivative	(239,278)	(60,504)
Loss on debt conversion	27,504	254,884
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(30,865)	(104,071)
Accounts payable and accrued expenses	1,600,849	644,329
Accounts payable to related party	34,109	(216,680)
Net cash used in operating activities	(3,366,602)	(1,324,317)
Cash flows from financing activities:
Proceeds from private placement	1,613,200	2,304,541
Proceeds from sales of common stock	118,594
Proceeds from convertible debt	300,000
Proceeds from convertible notes and short term loans, others	1,020,875
Repaid to note holder	(100,000)
Repaid to others	(75,000)
Proceeds from Payroll Protection Plan	92,995	250,000
Proceeds from short term loan, related party		70,000
Net cash provided by financing activities	2,970,664	2,624,541
Net (decrease) increase in cash	(395,938)	1,300,224
Cash and restricted cash - beginning of period	494,019	81,964
Cash and restricted cash - end of period	98,081	1,382,188
Supplemental cash flow information:
Interest paid
Non-cash investing and financing activities:
Warrants issued in connection with private placement	2,190,127
Common shares issued upon partial conversion of debt	210,301	900,569
Common shares issued in lieu of services	93,641
Common shares issued in lieu of restricted stock units	226,432
Non-cash cost upon sale of common stock	39,991
Beneficial Conversion Feature on convertible debt and restricted common shares	$ 605,719